Haemolytic anaemias Flashcards

Autoimmune Haemolytic anaemia RBC membrane defects (G6PD, spherocytosis, eliptocytosis) MAHAs (HUS +TTP)

1
Q

What are the different causes for congenital haemolytic anaemias?

A
  1. Inherited (most)
  2. Haemolytic disease of the newborn (ABO/Rh) due to trans placental passage of antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which “sites” of the RBC can abnormalities occur in inherited haemolytic anaemias?

A
  1. RBC membrane
  2. Haemoglobin moleculse
  3. RBC enzymes: glycolytic pathway and pentose shunt
  4. Other rare conditions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are typical features of haemolytic anaemias on Blood tests?

A
  1. FBC
    - anaemia
    - increased production: reticulocytes
  2. Evidence of breakdown
    - jaundice, bilirubin, LDH?
  3. Are there abnormal cells?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common Red cell membrane defects?

A
  1. Hereditary spherocytosis
  2. hereditary elpitocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the pathophysiology of hereditary spherocytosis

A

Genetic mutation impact the connection of the cell membrane to the lipid layer –> makes RBC more round and more stiff as they age

  1. Splenomegaly –> causes splenic infarction
  2. Extravascular haemolytic –> destruction via splenic macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are clinical features of hereditary spherocytosis?

A

Often asymptomatic

  1. anaemia
  2. jaundice
  3. Pigment gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is a diagnosis of Hereditary Spherocytosis made?

What are the expected results for each of the investigations?

A
  1. FBC&LFT
    - may/may not anaemia
    - MCHC often increased
    - Increased reticulocytes
    - Bilirubin + LDH increased

Film
- spherocytosis + polychromasia + increased reticulocytes

Important differential for Spherocytes: autoimmune haemolytic anaemia (perform a negative direct anti globulin test - negative in hereditary spherocytosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the epidemiology of hereditary spherocytosis?

A

1 in 1.000 - 1 in 3.000 in caucasians

75% autosomal dominant

25% spontaneous or autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the epidemiology of hereditary spherocytosis?

A

1 in 1.000 - 1 in 3.000 in caucasians

75% autosomal dominant

25% spontaneous or autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the epidemiology + clinical significance of hereditary eliptocytosis?

A

2% of west Africans, rare in caucasians

Usually no clinical significance (asymptomatic + incidental diagnosis)

Might cause symptomatic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What disorder is a RBC disorder in the Glycolytic pathway?

How common is it?

A

All Glycolytic pathway defect are rare

Most common of the rare conditions
1. Pyruvate kinase deficiency - chronic haemolytic anaemia but usually asymptomatic/ little clinical significance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathophysiology of G6PD deficiency?

A

Defect in pentose shunt

Reduced levels of glutathione lead to increases susceptibility of RBC to oxidative stress+ free radicals
–> increased RBC membrane damage
–> increased intravascular and extravascular haemolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the epidemiology of G6PD deficiency?

A

x-linked recessive disease (male)

Usually Mediterranean + Afro-carribeans and other African descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is usually the first clinical presentation of G6PD deficiency?

A

Can present as
- neonatal jaundice
- acute intermittent haemolytic in times of oxidative stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common triggers for an haemolytic episode in patients with G6PD deficiency?

A
  1. Infections (reactive oxygen generated by neutrophils)
  2. Food: Fava beans
  3. Drugs: antimalarials, nitrofurantoin, isoniazid, etc.

Other chemicals: moth balls ( naphthalene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the blood film of a patient with G6PD deficiency show?

A

Can be normal if no oxidative stress

In oxidative stress
- Anaemia
- irregular contracted cells
- hemighost, ghost cell (empty membrane)
- Heinz bodies

  • increased reticulocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is the diagnosis of G6PD deficiency made?

A

G6PD assay

but can be normal in acute haemolytic with high reticulocytes, as reticulocytes have higher levels of the enzyme

18
Q

How is G6PD deficiency managed?

A
  1. Prevention: avoid foods, certain drugs
  2. in crisis: transfusion might be ecessary
19
Q

What is autoimmune haemolytic anaemia?

A

Antibodies are produced against erythrocyte antigens leding to haemolytic anaemia due to intravascular and extravascular haemolysis

20
Q

How is autoimmune haemolytic anaemia diagnosed?

A

By a Direct antiglobulin test ( Coombs test)

–> Test to identify immunoglobulins and complements on the RBC membrane

21
Q

What is the cause of autoimmune haemolytic anaemia?

A

Most commonly idiopathic

Are associated with several other diseases, such as
- SLE
(can also be associated with lymphoma, other malignancies)

22
Q

What is the difference between Warm and cold autoimmune haemolytic anaemias?

Features and Causes
Causes

A

The temperature at which the agglutination is most pronounced

23
Q

How is warm AIHA usually managed?

A
  1. Steroids
  2. Splenectomy
  3. Immunosuppressionn (Rituximab)
24
Q

How is cold AIHA usually managed?

A
  1. Treat underlying condition
  2. Avoid the cold
  3. If lymphoma: chemotherapy
24
Q

How is cold AIHA usually managed?

A
  1. Treat underlying condition
  2. Avoid the cold
  3. If lymphoma: chemotherapy
25
Q

What is Microangiopathic haemolytic anaemias?
What are common causes?

A

Pathological processes in capillaries cause fragmentation of red cells

There are many causes
Some causes include
1. HUS
2. TTP
3. Metastatic tumours
4. DIC

26
Q

What is HUS? Explain the pathophysiology

A

Infection with E.coli O157:H7
–> production of toxins that lead to endothelial cell damage (particularly in kidneys)
–> Vasoconstriction and thrombus formation

27
Q

What is the common clinical presentation of HUS?

A

Usually infant - child

Haematology is proceeded by 5-10 days of bloody diarrhoea

with
1. Jaundice + clinical features of anaemia + oliguria

28
Q

What is the clinical triad of Presentation of HUS?

A
  1. Thrombocytopenia
    - Petechiae, purpura
    - Mucosal bleeding
    - Prolonged bleeding after minor cuts
  2. Microangiopathic hemolytic anemia
    - Fatigue, dyspnea, and pallor
    - Jaundice
  3. Impaired renal function
    - Hematuria, proteinuria
    - Oliguria, anuria
29
Q

What is the difference between HUS and TTP?

A

Both cause thrombotic MAHA (microangiopathic haemolytic anaemias) with the same pathophysiology.

  1. HUS: is caused by an external trigger (e.coli infection)
  2. TTP is autoimmune

Clinically similar presentation but TTP has neurological involvement, HUS not

30
Q

What does the blood film of MAHA show?

A
  • schistocytes (fragmented RBC)
  • thrombopenia
31
Q

What are expected blood results of MAHA?

A

FBC + LFTs
- anaemia
- reticulocytosis
- increased bilirubin + LDH

(in HUS: increased creatinine?)

32
Q

What is the confirmatory test for a diagnosis of hereditary spherocytosis?

A

Reduced red cell binding to eosin-5-maleimide

33
Q

What is Thrombotic thrombocytopenic purpura?

A

thrombotic Microangiopathic haemolytic anaemia, caused by (usually) autoimmune destruction of the ADAMTS13 (VWBf -cleaving protease)

34
Q

Explain the pathophysiology of TTP

A
  1. Autoantibodies or gene mutations → deficiency of ADAMTS13 (a metalloprotease that cleaves von Willebrand factor)
  2. ↓ Breakdown of vWF multimers → vWF multimers accumulate on endothelial cell surfaces
  3. Platelet adhesion and microthrombosis
  4. Microthrombi → fragmentation of RBCs with schistocyte formation → hemolytic anemia
  5. Arteriolar and capillary microthrombosis → end-organ ischemia and damage, especially in the brain and kidneys (potentially resulting in acute kidney injury or stroke)
35
Q

What is the clinical presentation of TTP?

A

Pentad of clinical symptoms in ADULTS (usually)

  1. Fever
  2. Neurological signs + symptoms

+ Triad of HUS
1. Thrombocytopenia
2. Haemolytic anaemia
3. Renal impairment

36
Q

What are biochemical + blood film presentations of TTP?

A

Thrombocytopenia
Red cell fragments
Polychromasia

+ increase creatinine (renal impairment) + signs of haemolytic

37
Q

What is your confirmatory test for the diagnosis of TTP?

A

Clinical diagnosis + reduced ADAMTS13 and the presence of ADAMTS13 inhibitors

38
Q

How is TTP managed?

A

Medical emergency - usually start treatment before confirmed diagnosis to reduce mortality

  1. Plasmapheresis (remove autoantibodies and replace ADAMTS13)
  2. immunosuppression
    ? Caplacizumab (WVF antibody)

NO platelet transfusion –> might make microangiopathy worse

39
Q

What happens to haptoglobin in haemolytic anaemias?

Why?

A

Would be low

Because Haptoglobin binds free Hb

Haemolysis –> High free Hb –> Low Haptoglobin